A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

A survey of more than 20,000 patients revealed a lack of trust in information about cancer, whether it comes from scientists, ...

[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...

Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...

Insurance companies pledged to reduce wait times for prior authorization approvals, with support from Dr Mehmet Oz.

Prademagene zamikeracel, a gene-modified treatment applied surgically, was seen to increase wound healing and pain in RDEB.

The leading causes of readmission among patients who received THA included sepsis (14.6%), nonseptic infections (14.8%), ...

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.